EcoDrugPlus

Cyclin Dependent Kinase 6

Ensembl ID : ENSCGOG00000015501
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSCGOG00000009523
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSCGOG00000014213
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCGOG00000004220
Gene Symbol: CYSLTR1
1 Cross references
180 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSCGOG00000002198
Gene Symbol: LOC115008834
3 Cross references
198 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSCGOG00000017922
Gene Symbol: LOC115024622
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSCGOG00000006065
Gene Symbol: LOC115008590
3 Cross references
494 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSCGOG00000024084
Gene Symbol: LOC115020285
3 Cross references
560 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSCGOG00000001578
Gene Symbol: LOC115010822
2 Cross references
469 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSCGOG00000006100
Gene Symbol: LOC115008600
3 Cross references
573 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSCGOG00000010768
Gene Symbol: CYP19A1
3 Cross references
246 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSCGOG00000014567
Gene Symbol: LOC115004524
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).